Schizophrenia Research
Volume 120, Issue 1 , Pages 7-15 , July 2010

Should a “Risk Syndrome for Psychosis” be included in the DSMV?

  • Alison R. Yung

      Affiliations

    • Orygen Youth Health Research Centre and Centre for Youth Mental Health, University of Melbourne, 35 Poplar Rd, Parkville, Vic 3052, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 3 93422800; fax: +61 3 93422921.
    • ,
  • Barnaby Nelson

      Affiliations

    • Orygen Youth Health Research Centre and Centre for Youth Mental Health, University of Melbourne, 35 Poplar Rd, Parkville, Vic 3052, Australia
    • Tel.: +61 3 93422800.
    • ,
  • Andrew D. Thompson

      Affiliations

    • Orygen Youth Health Research Centre and Centre for Youth Mental Health, University of Melbourne, 35 Poplar Rd, Parkville, Vic 3052, Australia
    • Tel.: +61 3 93422800.
    • ,
  • Stephen J. Wood

      Affiliations

    • Melbourne Neuropsychiatry Centre, University of Melbourne, Grattan St, Parkville, Vic 3052, Australia
    • Tel.: +61 3 83441877.

Received 11 January 2010 ,Accepted 12 March 2010.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. Washington DC: American Psychiatric Association; 1994;
  2. Amminger GP, Schaefer MR, Papageorgiou K, Becker J, Mossaheb N, Harrigan SM, et al. Omega-3 fatty acids reduce the risk of early transition to psychosis in ultra-high risk individuals: a double-blind randomized, placebo-controlled treatment study. Schizophrenia Bulletin. 2007;33:418–419
  3. Amminger GP, Schäfer M, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, et al. Long-Chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Archives of General Psychiatry. 2010;67(2):146–154
  4. Andreasen NC. DSM and the death of phenomenology in America: an example of unintended consequences. Schizophrenia Bulletin. 2007;33:108–112
  5. Bechdolf A, Phillips LJ, Francey SM, Leicester S, Morrison AP, Veith V, et al. Recent approaches to psychological interventions for people at risk of psychosis. European Archives of Psychiatry and Clinical Neuroscience. 2006;256:159–173
  6. Bombard Y, Veenstra G, Friedman JM, Creighton S, Currie L, Paulsen JS, et al. Perceptions of genetic discrimination among people at risk for Huntington's disease: a cross sectional survey. BMJ. 2009;338:b2175
  7. Boorse C. On the distinction between disease and illness. Philosophy and Public Affairs. 1975;5:49–68
  8. Brewer WJ, Wood SJ, McGorry PD, Francey SM, Phillips LJ, Yung AR, et al. Impairment of olfactory identification ability in individuals at Ultra-High Risk for psychosis who later develop schizophrenia. American Journal of Psychiatry. 2003;160:1790–1794
  9. Brewer WJ, Francey SM, Wood SJ, Jackson HJ, Pantelis C, Phillips LJ, et al. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. American Journal of Psychiatry. 2005;162:71–78
  10. Broome MR, Woolley JB, Johns LC, Valmaggia LR, Tabraham P, Gafoor R, et al. Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state. European Psychiatry. 2005;20:372–378
  11. Broome MR, Matthiasson P, Fusar-Poli P, Woolley JB, Johns LC, Tabraham P, et al. Neural correlates of executive function and working memory in the ‘at-risk mental state’. British Journal of Psychiatry. 2009;194:25–33
  12. Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Archives of General Psychiatry. 2008;65:28–37
  13. Carpenter WT. Anticipating DSM-V: should psychosis risk become a diagnostic class?. Schizophrenia Bulletin. 2009;35:841–843
  14. Cooper R. What is wrong with the DSM?. History of Psychiatry. 2004;15:5–25
  15. Corcoran C, Malaspina D, Hercher L. Prodromal interventions for schizophrenia vulnerability: the risks of being “at risk”. Schizophrenia Research. 2005;73:173–184
  16. Cornblatt BA, Lencz T, Smith CW, Correll CU, Auther AM, Nakayama E. The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophrenia Bulletin. 2003;29:633–651
  17. Corrigan PW, Watson AC, Barr L. The self-stigma of mental illness: implications for self-esteem and self-efficacy. Journal of Social and Clinical Psychology. 2006;25:875–884
  18. Crossley NA, Mechelli A, Fusar-Poli P, Broome MR, Matthiasson P, Johns LC, et al. Superior temporal lobe dysfunction and frontotemporal dysconnectivity in subjects at risk of psychosis and in first-episode psychosis. Human Brain Mapping. 2009;30(12):4129–4137
  19. Dhossche D, Ferdinand R, Van der Ende J, Hofstra MB, Verhulst F. Diagnostic outcome of self-reported hallucinations in a community sample of adolescents. Psychological Medicine. 2002;32:619–627
  20. Eastvold AD, Heaton RK, Cadenhead KS. Neurocognitive deficits in the (putative) prodrome and first episode of psychosis. Schizophrenia Research. 2007;93:266–277
  21. Falloon IRH. Early intervention for first episodes of schizophrenia: a preliminary exploration. Psychiatry. 1992;55:4–15
  22. First MB, Pincus HA, Levine JB, Williams JBW, Ustun B, Peele R. Clinical utility as a criterion for revising psychiatric diagnoses. American Journal of Psychiatry. 2004;161:946–954
  23. Frances A. A warning sign on the road to DSM-V: beware of its unintended consequences. Psychiatric Times. 2009;26(8):1–7
  24. Francey SM, Jackson HJ, Phillips LJ, Wood SJ, Yung AR, McGorry PD. Sustained attention in young people at high risk of psychosis does not predict transition to psychosis. Schizophrenia Research. 2005;79:127–136
  25. Gross G. The “basic” symptoms of schizophrenia. British Journal of Psychiatry. 1989;155(Suppl. 7):21–25
  26. Grube M. Towards an empirically based validation of intuitive diagnostic: Rumke's ‘praecox feeling’ across the schizophrenia spectrum: preliminary results. Psychopathology. 2006;39:209–217
  27. Hafner H. The concept of disease in psychiatry. Psychological Medicine. 1987;17:11–14
  28. Hafner H, Maurer K, Trendler G, an der Heiden W, Schmidt M. The early course of schizophrenia and depression. European Archives of Psychiatry and Clinical Neuroscience. 2005;255:167–173
  29. Hanssen M, Peeters F, Krabbendam L, Radstake S, Verdoux H, van Os J. How psychotic are individuals with non-psychotic disorders?. Social Psychiatry and Psychiatric Epidemiology. 2003;38:149–154
  30. Hanssen M, Bak M, Bijl R, Vollebergh W, van Os J. The incidence and outcome of subclinical psychotic experiences in the general population. British Journal of Clinical Psychology. 2005;44:181–191
  31. Haroun N, Dunn L, Haroun A, Cadenhead K. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophrenia Bulletin. 2006;32:166–178
  32. Heckers S. Who is at risk for a psychotic disorder?. Schizophrenia Bulletin. 2009;35:847–850
  33. Howes OD, Montgomery AJ, Asselin M-C, Murray RM, Valli I, Tabraham P, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Archives of General Psychiatry. 2009;66:13–20
  34. Huber G, Gross G, Schuttler R, Linz M. Longitudinal studies of schizophrenic patients. Schizophrenia Bulletin. 1980;6:592–605
  35. International Early Psychosis Association , Addington J, Amminger GP, Barbato A, Catts S, Chen E, et al. International clinical practice guidelines for early psychosis. British Journal of Psychiatry. 2005;187:120–124
  36. Jessen F, Scherk H, Traber F, Theyson S, Berning J, Tepest R, et al. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia. Schizophrenia Research. 2006;87:81–88
  37. Kendell RE. The concept of disease and its implications for psychiatry. British Journal of Psychiatry. 1975;127:305–315
  38. Kendell RE, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. American Journal of Psychiatry. 2003;160:4–12
  39. Kendler KS. Toward a scientific psychiatric nosology. Strengths and limitations. Archives of General Psychiatry. 1990;47:969–973
  40. Keogh LA, van Vliet CM, Studdert DM, Maskiell JA, Macrae FA, St John DJ, et al. Is uptake of genetic testing for colorectal cancer influenced by knowledge of insurance implications?. Medical Journal of Australia. 2009;191:255–258
  41. Klosterkotter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Archives of General Psychiatry. 2001;58:158–164
  42. Krabbendam L, Janssen I, Bak M, Bijl RV, de Graaf R, van Os J. Neuroticism and low self-esteem as risk factors for psychosis. Social Psychiatry and Psychiatric Epidemiology. 2002;37:1–6
  43. Krabbendam L, Myin-Germeys I, Hanssen M, de Graaf R, Vollebergh W, Bak M, et al. Development of depressed mood predicts onset of psychotic disorder in individuals who report hallucinatory experiences. British Journal of Clinical Psychology. 2005;44:113–125
  44. Landin R, DeBrota DJ, DeVries TA, Potter WZ, Demitrack MA. The impact of restrictive entry criterion during the placebo lead-in period. Biometrics. 2000;56:271–278
  45. Lencz T, Smith CW, Auther A, Correll CU, Cornblatt B. Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophrenia Research. 2004;68:37–48
  46. Lewis J, Konda V, Rubin DT. Genetic testing for inflammatory bowel disease: focus group analysis of patients and family members. Genetic Testing and Molecular Biomarkers. 2009;13:495–503
  47. Loewy RL, Bearden CE, Johnson JK, Raine A, Cannon TD. The prodromal questionnaire (PQ): preliminary validation of a self-report screening measure for prodromal and psychotic syndromes. Schizophrenia Research. 2005;79(1):117–125(Nov)
  48. Mason O, Startup M, Halpin S, Schall U, Conrad A, Carr V. Risk factors for transition to first episode psychosis among individuals with ‘at-risk mental states’. Schizophrenia Research. 2004;71:227–237
  49. Matthews E. The relevance of phenomenology. Philosophy, Psychiatry and Psychology. 2005;12:205–207
  50. McFarlane W, Cook W, Downing D, Maloney A. Portland Identification and Early Referral ( PIER): conversion and incidence outcomes in a catchment-area-wide psychosis prevention program, 1994–2008. Early Intervention in Psychiatry. 2008;2(Suppl 1):11
  51. McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. American Journal of Psychiatry. 2006;163:790–799
  52. McGlashan TH, Addington J, Cannon T, Heinimaa M, McGorry P, O'Brien M, et al. Recruitment and treatment practices for help-seeking “prodromal” patients. Schizophrenia Bulletin. 2007;33:715–726
  53. McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry. 2002;59:921–928
  54. Miller TJ, McGlashan TH, Rosen JL, Somjee L, Markovich PJ, Stein K, et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. American Journal of Psychiatry. 2002;159:863–865
  55. Morley J. Phenomenological and biological psychiatry: complementary or mutual?. Philosophy, Psychiatry and Psychology. 2002;9:87–90
  56. Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. British Journal of Psychiatry. 2004;185:291–297
  57. Nelson B, Yung AR. When things are not as they seem: detecting first episode psychosis upon referral to ultra high risk (“prodromal”) clinics. Early Intervention in Psychiatry. 2007;1:208–211
  58. Nelson B, Yung AR. Psychotic-like experiences as overdetermined phenomena: when do they increase risk for psychotic disorder. Schizophrenia Research. 2009;108:303–304
  59. Nelson, B., and Yung, A.R., in press. Can clinicians predict psychosis in an ultra high risk group? Australian and New Zealand Journal of Psychiatry.
  60. Nelson B, Simmons MB, Yung AR, Buckby JA, O'Dwyer L, Francey SM, et al. Identifying the ultra-high risk (‘prodromal’) population: evaluation of training workshops with mental health services. Australian and New Zealand Journal of Psychiatry. 2008;42:236–243
  61. Nelson B, Yung AR, Bechdolf A, McGorry PD. The phenomenological critique and self-disturbance: implications for ultra-high risk (‘prodrome’) research. Schizophrenia Bulletin. 2008;34:381–392
  62. Nieman D, Becker H, van de Fliert R, Plat N, Bour L, Koelman H, et al. Antisaccade task performance in patients at ultra high risk for developing psychosis. Schizophrenia Research. 2007;95:54–60
  63. Olsen KA, Rosenbaum B. Prospective investigations of the prodromal state of schizophrenia: review of studies. Acta Psychiatrica Scandinavica. 2006;113:247–272
  64. Parnas J. Clinical detection of schizophrenia-prone individuals: critical appraisal. British Journal of Psychiatry. Special Issue: Early Psychosis: A Bridge to the Future. 2005;187:s111–s112
  65. Parnas J, Zahavi D. The link: philosophy–psychopathology–phenomenology. In:  Zahavi D editors. Exploring the self: Philosophical and Psychopathological Perspectives on Self-experience. Amsterdam: John Benjamins; 2000;p. 1–16
  66. Parnas J, Zahavi D. The role of phenomenology in psychiatric classification and diagnosis. In:  Maj M,  Gaebel W,  Lopez-Ibor JJ editor. Psychiatric Diagnosis and Classification. Chichester, UK: John Wiley; 2002;p. 137–162
  67. Parnas J, Sass LA, Zahavi D. Recent developments in philosophy of psychopathology. Current Opinion in Psychiatry. 2008;21:578–584
  68. Peters ER, Joseph SA, Garety PA. Measurement of delusional ideation in the normal population: introducing the PDI (Peters et al. Delusions Inventory). Schizophrenia Bulletin. 1999;25:553–576
  69. Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Archives of General Psychiatry. 2000;57:1053–1058
  70. Pulst SM. Neurodegenerative disease. Genetic discrimination in Huntington disease. Nature Reviews Neurology. 2009;5:525–526
  71. RANZCP Clinical Practice Guidelines Team . Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry. 2005;39:1–30
  72. Reich W. Psychiatric diagnosis as an ethical problem. In:  Bloch S,  Chodoff P,  Green SA editor. Psychiatric Ethics. 3rd Edn.. Oxford: Oxford University Press; 1999;p. 193–224
  73. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. American Journal of Psychiatry. 1970;126:983–987
  74. Ruhrmann S. Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis. British Journal of Psychiatry. 2007;191:S88–S95
  75. Ruhrmann S, Schultze-Lutter F, Klosterkotter J. Early detection and intervention in the initial prodromal phase of schizophrenia. Pharmacopsychiatry. 2003;36:S162–S167
  76. Rümke C. The nuclear symptom of schizophrenia and the praecox feeling. History of Psychiatry. 1941/1990;1:331–341
  77. Sass LA, Parnas J. Schizophrenia, consciousness, and the self. Schizophrenia Bulletin. 2003;29:427–444
  78. Schobel SA, Lewandowski NM, Corcoran CM, Moore H, Brown T, Malaspina D, et al. Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. Archives of General Psychiatry. 2009;66:938–946
  79. Schultze-Lutter F. Subjective symptoms of schizophrenia in research and the clinic: the basic symptom concept. Schizophrenia Bulletin. 2009;35:5–8
  80. Schultze-Lutter F, Ruhrmann S, Berning J, Maier W, Klosterkötter J. Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state. Schizophrenia Bulletin. 2008;36:182–191
  81. Schwartz MA, Wiggins OP. Typifications. The first step for clinical diagnosis in psychiatry. Journal of Nervous and Mental Disease. 1987;175:65–77
  82. Scott J, Chant D, Andrews G, McGrath J. Psychotic-like experiences in the general community: the correlates of CIDI psychosis screen items in an Australian sample. Psychological Medicine. 2006;36:231–238
  83. Simon AE, Dvorsky DN, Boesch J, Roth B, Isler E, Schueler P, et al. Defining subjects at risk for psychosis: a comparison of two approaches. Schizophrenia Research. 2006;81:83–90
  84. Spitzer R. A proposal about homosexuality and the APA nomenclature: homosexuality as an irregular form of sexual behavior and sexual orientation disturbance as a psychiatric disorder. American Journal of Psychiatry. 1973;130:210–215
  85. Svirskis T, Korkeila J, Heinimaa M, Huttunen J, Ilonen T, Ristkari T, et al. Axis-I disorders and vulnerability to psychosis. Schizophrenia Research. 2005;75(2–3):439–446(Jun)
  86. Tien AY. Distributions of hallucinations in the population. Social Psychiatry and Psychiatric Epidemiology. 1991;26:287–292
  87. van Os J, Hanssen M, Bijl RV, Vollebergh W. Prevalence of psychotic disorder and community level of psychotic symptoms: an urban–rural comparison. Archives of General Psychiatry. 2001;58:663–668
  88. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness–persistence–impairment model of psychotic disorder. Psychological Medicine. 2008;1–17
  89. Velakoulis D, Wood SJ, Wong MT, McGorry PD, Yung A, Phillips L, et al. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Archives of General Psychiatry. 2006;63:139–149
  90. Verdoux H, Maurice-Tison S, Gay B, van Os J, Salamon R, Bourgeois ML. A survey of delusional ideation in primary-care patients. Psychological Medicine. 1998;28:127–134
  91. Verdoux H, van Os J, Maurice-Tison S, Gay B, Salamon R, Bourgeois ML. Increased occurrence of depression in psychosis-prone subjects: a follow-up study in primary care settings. Comprehensive Psychiatry. 1999;40:462–468
  92. Weiser M, van Os J, Reichenberg A, Rabinowitz J, Nahon D, Kravitz E, et al. Social and cognitive functioning, urbanicity and risk for schizophrenia. British Journal of Psychiatry. 2007;191:320–324
  93. Wood SJ, Berger G, Velakoulis D, Phillips LJ, McGorry PD, Yung AR, et al. Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals. Schizophrenia Bulletin. 2003;29:831–843
  94. Wood SJ, Yucel M, Yung AR, Berger GE, Velakoulis D, Pantelis C. The transition to psychosis: risk factors and brain changes. Epidemiologia e Psichiatria Sociale. 2004;13:137–140
  95. Wood SJ, Brewer W, Koutsouradis P, Phillips LJ, Francey SM, Proffitt T, et al. Cognitive decline following psychosis onset: data from the PACE clinic. British Journal of Psychiatry. 2007;191(Suppl 51):52–57
  96. Wood SJ, Pantelis C, Proffit T, Phillips LJ, Stuart GW, Buchanan J-A, et al. Spatial working memory ability is a marker of risk-for-psychosis. Psychological Medicine. 2003;33(7):1239–1247
  97. Woods S, Addington J, Cadenhead K, Cannon T, Cornblatt B, Heinssen B, et al. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophrenia Bulletin. 2009;894–908
  98. Yücel M, Wood SJ, Phillips LJ, Stuart GW, Smith D, Yung AR, et al. Morphological anomalies of the anterior cingulate cortex in young individuals at ultra high-risk of developing a psychotic illness. British Journal of Psychiatry. 2003;182:518–524
  99. Yung AR. The schizophrenia prodrome: a high risk concept. Schizophrenia Bulletin. 2003;29:857–863
  100. Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophrenia Bulletin. 1996;22:283–303
  101. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, et al. Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophrenia Research. 2003;60:21–32
  102. Yung AR, Phillips LJ, McGorry PD. Treating Schizophrenia in the Prodromal Phase. London: Taylor and Francis; 2004;
  103. Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophrenia Research. 2004;67:131–142
  104. Yung AR, Buckby JA, Cotton SM, Cosgrave EM, Killackey EJ, Stanford C, et al. Psychotic-like experiences in non-psychotic help-seekers: associations with distress, depression and disability. Schizophrenia Bulletin. 2006;32:352–359
  105. Yung AR, Stanford C, Cosgrave E, Killackey E, Phillips L, Nelson B, et al. Testing the Ultra High Risk (Prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophrenia Research. 2006;84:57–66
  106. Yung AR, Buckby JA, Cosgrave EM, Killackey EJ, Baker K, Cotton SM, et al. Association between psychotic experiences and depression in a clinical sample over 6months. Schizophrenia Research. 2007;91:246–253
  107. Yung AR, Buckby JA, Cosgrave EM, Killackey EJ, Baker K, Cotton SM, et al. Association between psychotic experiences and depression in a clinical sample over 6months. Schizophrenia Research. 2007;91:246–253
  108. Yung AR, Nelson B, Stanford C, Simmons MB, Cosgrave EM, Killackey EJ, et al. Validation of “prodromal” criteria to detect individuals at Ultra High Risk of psychosis: 2year follow up. Schizophrenia Research. 2008;105:10–17
  109. Yung AR, Nelson B, Baker K, Buckby J, Baksheev G, Cosgrave E. Psychotic-like experiences in a community sample of adolescents: implications for the continuum model of psychosis and prediction of schizophrenia. Australian and New Zealand Journal of Psychiatry. 2009;43:118–128
  110. Yung, A.R., Phillips, L.J., Nelson, B., Francey, S., Yuen, H.P., Simmons, M.B., Ross, M., Kelly, D., Baker, K., Amminger, G.P., Berger, G., Thompson, A.D., McGorry, P.D., in press. Randomized controlled trial of interventions for young people at Ultra High Risk of psychosis: 6 month analysis. Journal of Clinical Psychiatry.

PII: S0920-9964(10)01187-4

doi: 10.1016/j.schres.2010.03.017

Schizophrenia Research
Volume 120, Issue 1 , Pages 7-15 , July 2010

Article Tools